LOGIN
Efficacy and Safety Of Loxoprofen Sodium Cataplasms In The Treatment Of Osteoarthritis
May 2025
Efficacy and Safety Of Loxoprofen Sodium Cataplasms In The Treatment Of Osteoarthritis
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Efficacy and safety of loxoprofen sodium cataplasms in the treatment of osteoarthritis: A randomized, multicenter study.
Biomed Rep . 2025 Feb 4;22(4):57.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Two hundred ninety-six patients with osteoarthritis were randomized to receive either loxoprofen sodium cataplasm (LSC) once daily (n=192) or flurbiprofen cataplasm (FPC) twice daily (n=104) for 2 weeks. The primary outcome was treatment effectiveness based on Visual Analog Scale (VAS), WOMAC global score, and Lysholm score. Secondary outcomes included changes in VAS, WOMAC subdomains (pain, stiff...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.